ArticleThe Journal of clinical investigation2010

Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.

Jian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.